ARCHIVES

Impact Of DRGs On Clinical Research Less Than First Feared, Speakers Tell NIH Directors Meeting

This article is from The Cancer Letter archive.

Vol. 12 No. 25 | June 20, 1986

Download PDF Visit The Full Archive

Related Articles

Taking on question of cost and outcomes, CMS turns to expert in cancer care quality.

June 3, 2005

Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II

September 26, 2014

In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved

April 4, 1980

NCI says SELECT study is close to full enrollment.

April 23, 2004

NIH Objects To Big Response On Immunology RFPs, But NCI Will Continue Wide Distribution

November 1, 1974

NIEHS Uses Gene Chips To Evaluate Chemicals.

March 3, 2000